atovaquone
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68462-421 -
Package NDC
68462-421-21 -
Package NDC
68462-421-69 -
Application number
ANDA209685 -
SPL ID
b221c446-0200-4c11-bd0c-ff9ec502bc19 -
SPL set ID
9045ba6f-938e-4717-bfa2-a3efe52f04cd -
UNII
Y883P1Z2LT -
RxCUI
308429
What the source publishes
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Active ingredients
- atovaquone
- Form
- SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "atovaquone",
"splId": "b221c446-0200-4c11-bd0c-ff9ec502bc19",
"labels": [
{
"setId": "9045ba6f-938e-4717-bfa2-a3efe52f04cd",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9045ba6f-938e-4717-bfa2-a3efe52f04cd",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9045ba6f-938e-4717-bfa2-a3efe52f04cd"
}
],
"routes": [
"ORAL"
],
"labeler": "Glenmark Pharmaceuticals Inc., USA",
"finished": true,
"packaging": [
{
"sample": false,
"description": "210 mL in 1 BOTTLE (68462-421-21)",
"package_ndc": "68462-421-21",
"identifierStatus": "well-formed",
"marketing_start_date": "20171231"
},
{
"sample": false,
"description": "42 POUCH in 1 CARTON (68462-421-69) / 5 mL in 1 POUCH",
"package_ndc": "68462-421-69",
"identifierStatus": "well-formed",
"marketing_start_date": "20171231"
}
],
"productId": "68462-421_b221c446-0200-4c11-bd0c-ff9ec502bc19",
"useDomain": "unknown",
"dosageForm": "SUSPENSION",
"productNdc": "68462-421",
"deaSchedule": null,
"genericName": "atovaquone",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ATOVAQUONE",
"strength": "750 mg/5mL"
}
],
"applicationNumber": "ANDA209685",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171231",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175482",
"N0000175485"
],
"upc": [
"0368462421215"
],
"unii": [
"Y883P1Z2LT"
],
"rxcui": [
"308429"
],
"spl_set_id": [
"9045ba6f-938e-4717-bfa2-a3efe52f04cd"
],
"pharm_class_epc": [
"Antimalarial [EPC]",
"Antiprotozoal [EPC]"
],
"manufacturer_name": [
"Glenmark Pharmaceuticals Inc., USA"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68462-421_b221c446-0200-4c11-bd0c-ff9ec502bc19"